Recombinant Human parathyroid hormone

Recombinant Human Parathyroid Hormone (rhPTH) is a synthetic version of the naturally-occurring parathyroid hormone, which is produced by specialized cells in the parathyroid gland. This hormone plays a crucial role in regulating calcium and phosphorus levels in the body.
Product Information:
Recombinant Human Parathyroid Hormone, also known as Teriparatide, is a prescription medication manufactured through biotechnology for the treatment of specific bone conditions that involve low bone density and decrease in bone strength.
Uses:
Teriparatide is primarily used in individuals with osteoporosis—a condition characterized by weak and porous bones, which increases the risk of fractures. It is effective in reducing the risk of spinal and non-spinal fractures, particularly in postmenopausal women who have experienced a recent vertebral fracture.
Aside from osteoporosis, Teriparatide is also used in certain cases of established osteoporosis—such as glucocorticoid-induced osteoporosis—where patients are currently receiving or have recently completed an oral corticosteroid dosage.
Administration & Dosage:
This medication is administered through a regular subcutaneous injection, typically during the morning, as directed by your healthcare provider. The dosage amount and frequency will be determined according to your specific condition and needs; follow these instructions carefully.
Precautions & Side Effects:
You should inform your healthcare provider before administering Teriparatide, as it may not be suitable in certain situations, such as during pregnancy or breastfeeding, or if you have a history of cancer or surgery involving the bones.
Common side effects of Teriparatide may include dizziness, headaches, or leg cramps. The medication may also cause an excessive increase in bone density, leading to bone pain or hypercalcaemia (high calcium levels), which requires regular monitoring by your healthcare team.